BROWSE·page 236 of 1397

Browse EX-10 agreements

16,757 total material contract exhibits.


EXHIBIT 10.5

Volkswagen Auto Lease Trust 2026-B

VOLKSWAGEN AUTO LEASE TRUST 2026-B

AMENDED AND RESTATED TRUST AGREEMENT

between

VOLKSWAGEN AUTO LEASE/LOAN UNDERWRITTEN FUNDING, LLC,
as the Transferor,

and

Deutsche Bank Trust Company Delaware,
as the Owner Trustee

Dated as of September 22, 2026

TABLE OF CONTENTS

** **

Page

ARTICLE I DEFINITIONS 1
SECTION 1.1 Capitalized Terms 1
SECTION 1.2 Other Interpretive Provisions 1

…

EX-10.5·8-K·CIK 2149941·ACC 0001104659-26-108499·Filed Sep 17, 2026, 12:25 ET

EX-10.1

Stepstone Private Credit Fund LLC

**EXECUTION VERSION **

**CREDIT AGREEMENT **

dated as of September 14, 2026

by and among

STEPSTONE SPV FACILITY VII LLC,

**as Borrower, **

STEPSTONE PRIVATE CREDIT FUND LLC,

**as Collateral Manager **

VARIOUS LENDERS,

GOLDMAN SACHS BANK USA,

**as Syndication Agent **

GOLDMAN SACHS BANK USA,

**as Administrative Agent **

GOLDMAN SACHS BANK USA,

**as Calculation Agent **

UMB BANK, NATIONAL ASSOCIATION,

**as Collateral Agent **

UMB BANK, NATIONAL ASSOCIATION,

**as Collateral Custodian **

UMB BANK, NATIONAL ASSOCIATION,** **

**as Collateral Administrator **


**TABLE OF CONTENTS **

…

EX-10.1·8-K·CIK 1950803·ACC 0001193125-26-393948·Filed Sep 17, 2026, 10:58 ET

EX-10.2

Stepstone Private Credit Fund LLC

**EXECUTION VERSION **

This **NON-RECOURSE CARVEOUT GUARANTY AGREEMENT **(this “Agreement”) is entered into as of September 14, 2026 (the “Closing Date”), by and among STEPSTONE SPV FACILITY VII INTERMEDIATE HOLDCO LLC, a Delaware limited liability company (the “Parent Guarantor”), and STEPSTONE PRIVATE CREDIT FUND LLC, a Delaware limited liability company (the “Fund Guarantor” and, together with the Parent Guarantor, each, a “Guarantor Entity” and, together with any additional guarantor entity made party from time to time to this Agreement, the “Guarantor Entities”), in favor of (a) UMB BANK, NATIONAL ASSOCIATION, as collateral agent (together with its successors and assigns in such capacity, the “Collateral Agent”) for and on behalf of the Secured Parties (as defined in the Credit Agreement referred to below), and (b) GOLDMAN SACHS BANK USA and its affiliates that are successors and assigns, as Lender, Administrative Agent and Calculation Agent (each as defined in the Credit Agreement referred to below).

…

EX-10.2·8-K·CIK 1950803·ACC 0001193125-26-393948·Filed Sep 17, 2026, 10:58 ET

EXHIBIT 10.2

LISATA THERAPEUTICS, INC.


Exhibit 10.2

SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of September 17, 2026, by and among Lisata Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the Persons listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).

WHEREAS, the Company and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act;

…

EX-10.2·8-K·CIK 320017·ACC 0001140361-26-036866·Filed Sep 17, 2026, 09:27 ET

EXHIBIT 10.1

LISATA THERAPEUTICS, INC.


Exhibit 10.1

REGISTRATION RIGHTS AGREEMENT

This Registration Rights Agreement (this “Agreement”) is dated as of September 17, 2026, by and between Lisata Therapeutics, Inc., a Delaware corporation (the “Company”), and the undersigned signatories hereto.

This Agreement is made in connection with that Agreement and Plan of Merger, dated as of the date hereof, by and among the Company, Marea Therapeutics, Inc., a Delaware corporation (“Marea”), Mariner Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“First Merger Sub”), and Mariner Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (“Second Merger Sub”) (as amended, restated, supplemented or otherwise modified from time to time, the “Merger Agreement”), pursuant to which the Company has agreed to issue shares of the Company’s Series C Non-Voting Convertible Preferred Stock, par value $0.01 per share (the “Preferred Shares”) and/or shares of Common Stock (as defined below, and collectively with the Preferred Shares, the “Shares”), to the equit

…

EX-10.1·8-K·CIK 320017·ACC 0001140361-26-036866·Filed Sep 17, 2026, 09:27 ET

EXHIBIT 10.3

LISATA THERAPEUTICS, INC.


Exhibit 10.3

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT(this “Agreement”), dated as of September 17, 2026, is entered into by and among Lisata Therapeutics, Inc., a Delaware corporation (the “Company”), and the several investors signatory hereto(individually as an “Investor” and collectively together with their respective permitted assigns, the “Investors”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and among the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

WHEREAS:

…

EX-10.3·8-K·CIK 320017·ACC 0001140361-26-036866·Filed Sep 17, 2026, 09:27 ET

Note: Qxpress Pte. Ltd. changed its name to Tracx Logis Pte. Ltd. as of November 18, 2024.

All references in this Plan to Qxpress refer to Tracx Logis.

*** ***

QXPRESS PTE. LTD.

(Incorporated in the Republic of Singapore)

Company Registration No. 201104738Z

2020 EMPLOYEE STOCK OPTION PLAN

1 PURPOSES
(a) ***Eligible Option Recipients. ***The persons eligible to receive Options are the Employees, Directors and Consultants of the Company and its Affiliates.

…

EX-10.1·F-1/A·CIK 2114145·ACC 0001213900-26-100785·Filed Sep 17, 2026, 09:27 ET

A LEASE mad. th^ I ^{\,. day of Between: (1) HSBC INSTITUTIONAL TRUST SERVICES (SinGAPORE) LIMITED (as trustee of unPLETREE LOGISTICS TRUST) (UNIQUE ENTITY No. 194900022R) a company incorporated in the Republic of Singapore and having its registered office at 10 Marina Boulevard #48-01 Marina Bay Financial Centre Tower 2 Singapore 018983 (hereinafter called "the Landlord" which expression shall include its successors and assigns) of the one part; and JLA ". @ (2) TRACX LOCIS PTE. LTD. (f. k. a. Q, ^RESS PTE. LTD. ) (UNIQUE ENTITY No. 20/104738Z), a companyincorporated in the Republic of Singapore and having its registered office at 5A Toh Guan Road East #06-03 CWT Jurong East Logistics Centre Singapore 608830 (hereinafter called "the Tenant', of the other part. Two thousand and Now THIS LEASE WITNESSETH as follows: Two"\^ , fiVA- (2021^') Definition I. 1.1 INTERPRETATION In this Lease and in any rules and regulations made hereunder or annexed hereto unless the contrary intention appears: (a) ^, t as "5A Toh Guan Road East" within which the Premises are situated and the expression "

…

EX-10.3·F-1/A·CIK 2114145·ACC 0001213900-26-100785·Filed Sep 17, 2026, 09:27 ET

EX-10.1

PETMED EXPRESS INC

EXECUTIVE EMPLOYMENT AGREEMENT

THIS EXECUTIVE EMPLOYMENT AGREEMENT (hereinafter “Agreement”) is made and entered into effective as of August 28, 2026, by and between PETMED EXPRESS, INC., a Florida corporation (“Company”), and JEFFREY ALLEN WILLARD, an individual (hereinafter called “Executive”).

RECITALS

WHEREAS, Company desires to retain the services of Executive as Chief Executive Officer and President of Company upon the terms and subject to the conditions set forth in this Agreement; and

WHEREAS, Executive desires to provide services to Company pursuant to the terms and conditions set forth in this Agreement

NOW THEREFORE, in consideration of the mutual covenants and promises set forth in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound, agree as follows:

1.    DUTIES AND SCOPE OF EMPLOYMENT.

…

EX-10.1·8-K·CIK 1040130·ACC 0001040130-26-000045·Filed Sep 17, 2026, 09:08 ET

EX-10.2

TuHURA Biosciences, Inc./NV

TUHURA BIOSCIENCES, INC.

2026 INDUCEMENT EQUITY INCENTIVE PLAN

STOCK OPTION AGREEMENT

You have been granted an option (this “Option”) to purchase shares of the common stock, par value $0.001 per share (the “Stock”), of TuHURA Biosciences, Inc. (the “Company”) pursuant to the Company’s 2026 Inducement Equity Incentive Plan (the “Plan”) and this Stock Option Agreement (this “Award Agreement”). This Option is granted under and governed by the terms and conditions of the Plan and this Award Agreement. Capitalized terms used but not defined in this Award Agreement shall have the meaning set forth in the Plan.

…

EX-10.2·8-K/A·CIK 1498382·ACC 0001193125-26-393847·Filed Sep 17, 2026, 09:00 ET

EX-10.1

TuHURA Biosciences, Inc./NV

TUHURA BIOSCIENCES, INC.

2026 INDUCEMENT EQUITY INCENTIVE PLAN

Adopted September 10, 2026

1. Purpose; Effective Date; Nasdaq Inducement Rules.

(a) Purpose. The TuHURA Biosciences, Inc. 2026 Inducement Equity Incentive Plan (the “Plan”) is intended to provide equity-based and cash incentive awards that qualify as employment inducement awards under the Nasdaq Rule. The Plan is intended to attract outstanding individuals to enter into employment with the Company or its Subsidiaries by offering such individuals the opportunity to acquire shares of the Company’s common stock, receive monetary payments based on the value of such common stock, or receive other incentive compensation, in each case as a material inducement to entering into employment with the Company or a Subsidiary.

…

EX-10.1·8-K/A·CIK 1498382·ACC 0001193125-26-393847·Filed Sep 17, 2026, 09:00 ET

Personal Employment Agreement

** **

This Personal Employment Agreement (this “Agreement”) is made as of September 15, 2026, by and between Duke Robotics Corp. a US Nevada State registered corporation, with offices at of 10 HaRimon Street, Mevo Carmel Science and Industrial Park, Israel (the “Company” or “Duke”) and **Avi Levin **(ID No.__________) (the “Executive”) of _____________________, Israel.

…

EX-10.1·8-K·CIK 1638911·ACC 0001213900-26-100765·Filed Sep 17, 2026, 08:35 ET